Healthcare

As the US-China Tariff War continues to escalate, the Transformational Healthcare Team at global research firm Frost & Sullivan has made available an insight analysis exploring the threats and opportunities for US businesses in China. The insight analysis also examines the timeline and causes of the tariff war and explores why medical technology (M...

The medical imaging and informatics industry is evolving rapidly, and new products and solutions are launched every other day. As the reimbursement environment is transitioning from fee-for-service to value-based payment, vendors’ business models and value propositions are undergoing drastic changes. New evidence regarding the use of certain tech...

The gastrointestinal tract has been one of the most difficult areas to evaluate with available imaging standards. Since the introduction of endoscope in 1960s, there have been continuous advances in endoscopy by replacing fiberoptics with CCD (Charge-coupled device) detectors. The Japanese method of staining mucosa with dye-spray called “chromoen...

This report aims to highlight the potential of Israel in becoming one of the leading centres for digital health innovation, globally. The report also presents some of the innovative startups working in the digital health space, as an example of the country’s potential.--BEGIN PROMO--

Research Scope

• Market  t...

  $1,500.00

  Special Price $1,125.00 save 25 %

  Read More

The neonatal care market is at a juncture where the rate of innovation in devices is much lower, resulting in flat prices and mid-single digit market growth, largely driven by replacement sales. This is especially true for phototherapy units and some respiration assistance devices. However, with increasing demand to provide cost-effective care and ...

Interest in the microbiome as a science and industry has exploded over the past decade. Innovations are happening across 3 significant categories for human health benefits: microbiome-based therapeutics, over-the-counter (OTC) dietary supplements, and self-diagnostics/screening. The OTC market is the largest because of the lack of precise regulatio...

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2019 that centered around the state of their laboratories in 2019 and their expectations for 2020. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year...

Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...

US-based providers lose an estimated $260 billion to $270 billion annually due to poor financial risk management and lack of infrastructure to support data-driven business decisions. For every dollar claimed, private and public payers on average offer a reimbursement of 86 cents to providers, resulting in a negative margin of 14% per dollar per pat...